Grantham, Mayo, Van Otterloo & Co (GMO)
HCM icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s HUTCHMED HCM Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio HCM Stock Details HCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-51,650
Closed -$763K – 734
2022
Q4 		$763K Buy
+51,650
New +$565K ﹤0.01% 536

Other funds holding HCM

MGIM
M&G Investment Management London, United Kingdom $28.2B AUM 25.87% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
AIA Group Hong Kong $6.88B AUM 20.97% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s HCM Position: Q1 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of HUTCHMED (HCM) in Q1 2023, closing a stake of 51,650 shares — an estimated $763K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HCM in Q4 2022 and held it in 1 quarter. The position peaked at $763K in Q4 2022. 71 funds tracked by Wall St. Rank hold HCM as of Q1 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining HUTCHMED position as of Q1 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 51,650 HUTCHMED shares in Q1 2023, an estimated $763K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HUTCHMED in Q4 2022 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s HUTCHMED position peaked at $763K in Q4 2022.
  • 71 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2023, filed 12 May 2023.